Kenyan researchers have identified two new strains of common sexually transmitted diseases among women in a western Kenya town. The discovery emerged while investigators were trying to understand rising STI cases in two hospitals in Busia County, which borders Uganda. More than 400 women over the age of 15 were diagnosed with gonorrhoea and chlamydia that carry novel mutations.
The Kenya Medical Research Institute (KEMRI) researchers warn that the infections could spread to neighboring Uganda, as Busia is a border town where truck drivers frequently stop. Epidemiologist Shillah Simiyu told *The Nation* that the high STI numbers in Busia are linked to increased sexual activity associated with its status as a transit hub. Simiyu emphasized the urgent need for a mixed‑methods study that combines social, epidemiological and laboratory approaches.
The team plans further investigations to determine how widespread the mutated strains are and whether standard antibiotics remain effective. According to the BBC, the genetic changes observed in the pathogens have not been seen before. In January 2023, drug‑resistant “super gonorrhoea” was first detected in samples from sex workers in Nairobi and other urban areas such as Kiambu County. The medical inquiry was sparked by a surge in STI patients toward the end of 2022, Dr. Amina Abdullahi of KEMRI told local media, as reported by DownToEarth.
Experts say the outbreak of *Neisseria gonorrhoeae* threatens not only Kenya but the wider East African region. The World Health Organization lists gonorrhoea as the second‑most common STI worldwide, after chlamydia. Kenya’s Ministry of Health documents, including the Kenya National Guidelines for Prevention, Management, and Control of STIs, estimate infertility prevalence at 11.9 %. Researchers warn that drug‑resistant gonorrhoea and other STIs could raise infertility rates, undermining the country’s development agenda.
A majority of Kenyans reportedly purchase antibiotics without seeking professional treatment, fostering STI mutations. A quick survey of chemists in Nairobi found that medication for “STI‑like symptoms” ranks among the top ten most frequently bought products.
Comments are closed for this story.